Prof Michael Berk
Professor Michael Berk is currently a NHMRC Senior Principal research Fellow, and is Alfred Deakin Chair of Psychiatry at Deakin University and Barwon Health, where he heads the IMPACT Strategic Research Centre. He also is an Honorary Professorial Research fellow in the Department of Psychiatry, the Florey Institute for Neuroscience and Mental Health and Orygen Youth Health at Melbourne University, as well as in the School of Public Health and Preventive Medicine at Monash University. He has published over 900 papers and is the 2nd highest cited bipolar disorder researcher in the world (Scopus), and is listed by Thompson Reuters as amongst the world’s most influential scientific minds. Data from SciVal shows he is Australia’s most highly cited researcher in the categories of neurosciences, and psychology and cognitive sciences over the five years between 2012 and 2017. He is past president of the International Society for Bipolar disorders and the Australasian Society or Bipolar and Depressive Disorders. His major interests are in the discovery and implementation of novel therapies, and risk factors and prevention of psychiatric disorders. He is the recipient of a number of national and international awards including the Brain & Behaviour (NARSAD) Colvin Award for Mood Disorders in 2015, and holds grants from the National Institutes of Health (US), Simon Autism Foundation, NHMRC CRE and project grants, Beyondblue and Stanley Medical Research Institute and is a lead investigator in a Collaborative Research Centre.